Beijing, 26 June 2026 – Beijing Chunlizhengda Medical Instruments Co., Ltd. (“Chunli Medical”) released an announcement detailing the latest composition of its Board of Directors and the membership of its four specialised committees.

Board Structure • Total directors: eight  – Executive Directors (4): Chairperson Ms. Shi Wenling, Mr. Shi Chunbao, Ms. Yue Shujun, Mr. Xie Feng Bao  – Non-Executive Director (1): Mr. Wang Xin  – Independent Non-Executive Directors (3): Ms. Xu Hong, Mr. Kwan King Nam, Mr. Zheng Zhong Liang

• General Manager: Mr. Shi Chunsheng

Committee Assignments 1. Audit Committee (4 members)  – Chair: Ms. Xu Hong  – Members: Mr. Wang Xin, Mr. Kwan King Nam, Mr. Zheng Zhong Liang

2. Remuneration Committee (2 members)  – Chair: Mr. Zheng Zhong Liang  – Member: Ms. Xu Hong

3. Nomination Committee (3 members)  – Chair: Ms. Xu Hong  – Members: Ms. Shi Wenling, Ms. Yue Shujun

4. Strategic Committee (4 members)  – Chair: Mr. Shi Chunbao  – Members: Ms. Shi Wenling, Mr. Xie Feng Bao, Mr. Wang Xin

The updated governance framework underscores Chunli Medical’s adherence to Hong Kong listing requirements, with independent directors holding key leadership roles in the Audit, Remuneration and Nomination Committees. The announcement does not disclose any changes to the company’s strategic direction or financial outlook.